Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

619 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk factors associated with cytomegalovirus infection in heart transplant patients: a prospective, epidemiological study.
Delgado JF, Manito N, Almenar L, Crespo-Leiro M, Roig E, Segovia J, Vázquez de Prada JA, Lage E, Palomo J, Campreciós M, Arizón JM, Rodríguez-Lambert JL, Blasco T, de la Fuente L, Pascual D, Rábago G. Delgado JF, et al. Among authors: segovia j. Transpl Infect Dis. 2011 Apr;13(2):136-44. doi: 10.1111/j.1399-3062.2010.00573.x. Epub 2010 Oct 5. Transpl Infect Dis. 2011. PMID: 21040280
Chronic renal dysfunction in maintenance heart transplant patients: the ICEBERG study.
González-Vílchez F, Arizón JM, Segovia J, Almenar L, Crespo-Leiro MG, Palomo J, Delgado JF, Mirabet S, Rábago G, Pérez-Villa F, Díaz B, Sanz ML, Pascual D, de la Fuente L, Guinea G; ICEBERG Study Group. González-Vílchez F, et al. Among authors: segovia j. Transplant Proc. 2014 Jan-Feb;46(1):14-20. doi: 10.1016/j.transproceed.2013.09.031. Transplant Proc. 2014. PMID: 24507019
Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?
Gonzalez-Vilchez F, Vazquez de Prada JA, Paniagua MJ, Gomez-Bueno M, Arizon JM, Almenar L, Roig E, Delgado J, Lambert JL, Perez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, Lopez-Granados A, Martinez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T. Gonzalez-Vilchez F, et al. Among authors: segovia j. Int J Cardiol. 2014 Jan 15;171(1):15-23. doi: 10.1016/j.ijcard.2013.11.036. Epub 2013 Nov 23. Int J Cardiol. 2014. PMID: 24309084
Comparison of the effectiveness of lovastatin therapy for hypercholesterolemia after heart transplantation between patients with and without pretransplant atherosclerotic coronary artery disease.
Anguita M, Alonso-Pulpón L, Arizón JM, Cavero MA, Vallés F, Segovia J, Pérez-Jiménez F, Crespo M, Concha M. Anguita M, et al. Among authors: segovia j. Am J Cardiol. 1994 Oct 15;74(8):776-9. doi: 10.1016/0002-9149(94)90433-2. Am J Cardiol. 1994. PMID: 7942548 Clinical Trial.
Incisional surgical infection in heart transplantation.
Ramos A, Asensio A, Muñez E, Torre-Cisneros J, Blanes M, Carratalá J, Segovia J, Munoz P, Cisneros JM, Bou G, Aguado JM, Cervera C, Gurgui MM. Ramos A, et al. Among authors: segovia j. Transpl Infect Dis. 2008 Jul;10(4):298-302. doi: 10.1111/j.1399-3062.2008.00316.x. Epub 2008 May 15. Transpl Infect Dis. 2008. PMID: 18482203
Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter study.
Podesser BK, Rinaldi M, Yona NA, Pulpón LA, Villemot JP, Haverich A, Duveau D, Brandrup-Wognsen G, Gronda E, Costard-Jäckle A, Crespo-Leiro MG, Khazen CS, Viganó M, Segovia J, Mattei MF, Harringer W, Treilhaud M, Karason K, Mangiavacchi M, Laufer G. Podesser BK, et al. Among authors: segovia j. Transplantation. 2005 Jan 15;79(1):65-71. doi: 10.1097/01.tp.0000140965.83682.d6. Transplantation. 2005. PMID: 15714171 Clinical Trial.
619 results